The Role of Ubiquitin-Proteasome System and Mitophagy in the Pathogenesis of Parkinson's Disease

被引:12
|
作者
Liang, Yu [1 ]
Zhong, Guangshang [2 ]
Ren, Mingxin [1 ]
Sun, Tingting [2 ]
Li, Yangyang [2 ]
Ye, Ming [3 ]
Ma, Caiyun [2 ]
Guo, Yu [2 ]
Liu, Changqing [1 ,2 ]
机构
[1] Bengbu Med Coll, Sch Clin Med, Bengbu 233000, Peoples R China
[2] Bengbu Med Coll, Sch Life Sci, Bengbu 233000, Peoples R China
[3] Bengbu Med Coll, Affiliated Hosp 1, Dept Neurol, Bengbu 233000, Peoples R China
基金
中国国家自然科学基金;
关键词
Ubiquitin proteasome system; Mitophagy; Parkinson's disease; ENDOPLASMIC-RETICULUM STRESS; ALPHA-SYNUCLEIN; MITOCHONDRIAL DYSFUNCTION; DEUBIQUITINATING ENZYMES; REGULATORY PARTICLE; SELECTIVE AUTOPHAGY; NERVOUS-SYSTEM; LEWY BODIES; CELL-DEATH; ER STRESS;
D O I
10.1007/s12017-023-08755-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a common neurodegenerative disease that is mainly in middle-aged people and elderly people, and the pathogenesis of PD is complex and diverse. The ubiquitin-proteasome system (UPS) is a master regulator of neural development and the maintenance of brain structure and function. Dysfunction of components and substrates of this UPS has been linked to neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. Moreover, UPS can regulate a-synuclein misfolding and aggregation, mitophagy, neuroinflammation and oxidative stress to affect the development of PD. In the present study, we review the role of several related E3 ubiquitin ligases and deubiquitinating enzymes (DUBs) on the pathogenesis of PD such as Parkin, CHIP, USP8, etc. On this basis, we summarize the connections and differences of different E3 ubiquitin ligases in the pathogenesis, and elaborate on the regulatory progress of different DUBs on the pathogenesis of PD. Therefore, we can better understand their relationships and provide feasible and valuable therapeutic clues for UPS-related PD treatment research.
引用
收藏
页码:471 / 488
页数:18
相关论文
共 50 条
  • [1] The Role of Ubiquitin–Proteasome System and Mitophagy in the Pathogenesis of Parkinson's Disease
    Yu Liang
    Guangshang Zhong
    Mingxin Ren
    Tingting Sun
    Yangyang Li
    Ming Ye
    Caiyun Ma
    Yu Guo
    Changqing Liu
    NeuroMolecular Medicine, 2023, 25 : 471 - 488
  • [2] Exploring the Role of Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease
    Zhao, Yiting
    Lin, Man
    Zhai, Fengguang
    Chen, Jun
    Jin, Xiaofeng
    PHARMACEUTICALS, 2024, 17 (06)
  • [3] Exploring the Role of Ubiquitin-Proteasome System in Parkinson's Disease
    Behl, Tapan
    Kumar, Sachin
    Althafar, Ziyad M.
    Sehgal, Aayush
    Singh, Sukhbir
    Sharma, Neelam
    Badavath, Vishnu Nayak
    Yadav, Shivam
    Bhatia, Saurabh
    Al-Harrasi, Ahmed
    Almoshari, Yosif
    Almikhlafi, Mohannad A.
    Bungau, Simona
    MOLECULAR NEUROBIOLOGY, 2022, 59 (07) : 4257 - 4273
  • [4] Ubiquitin-proteasome system and Parkinson's disease
    Olanow, C. Warren
    McNaught, Kevin St. P.
    MOVEMENT DISORDERS, 2006, 21 (11) : 1806 - 1823
  • [5] Dysfunction of the ubiquitin-proteasome system in Parkinson's disease
    Jenner, P
    JOURNAL OF NEUROCHEMISTRY, 2003, 85 : 1 - 1
  • [6] Failure of the ubiquitin-proteasome system in Parkinson's disease
    McNaught, KSP
    Olanow, CW
    Halliwell, B
    Isacson, O
    Jenner, P
    NATURE REVIEWS NEUROSCIENCE, 2001, 2 (08) : 589 - 594
  • [7] The ubiquitin-proteasome system and models of Parkinson's disease
    McNaught, KS
    Olanow, W
    MOVEMENT DISORDERS, 2004, 19 : S2 - S3
  • [8] A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease
    Cook, Casey
    Petrucelli, Leonard
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (07): : 664 - 675
  • [9] Ubiquitin-proteasome system and Parkinson's diseases
    Betarbet, R
    Sherer, TB
    Greenamyre, JT
    EXPERIMENTAL NEUROLOGY, 2005, 191 : S17 - S27
  • [10] Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses
    Moore, DJ
    Dawson, VL
    Dawson, TM
    NEUROMOLECULAR MEDICINE, 2003, 4 (1-2) : 95 - 108